NL-OMON35772已完成不适用
A multiple dose study to evaluate next day effects of MK-4305 on driving performance in healthy non-elderly subjects - Driving study with MK-4305 in non-elderly subjects
Merck Sharp & Dohme (MSD)0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age 21 till 64 (inclusive)
- •Possession of valid driving licence
- •Sufficient driving experience (at least 5000 km/year over the past 3 years)
排除标准
- •Use of medication that may influence driving performance
- •Excessive use of alcohol, nicotine or cafeine
- •Use of drugs
- •For women: pregnancy
研究者
相似试验
已完成
1 期
A study in healthy subjects to see the effects of the test medicine on the body when given in fed or fasted state as a multiple doseTransthyretin (TTR) Amyloidosis (ATTR)Digestive SystemISRCTN11628974Eidos Therapeutics, Inc.28
进行中（未招募）
1 期
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics) in healthy adultsHealthy Adult ParticipantsCTIS2022-502951-77-00Janssen - Cilag International20
进行中（未招募）
1 期
A study to evaluate the effect of multiple doses of carbamazepine and itraconazole on how long JNJ-55308942 stays in the body (pharmacokinetics) in healthy adults.Bipolar depressionCTIS2023-504055-27-00Janssen - Cilag International48
进行中（未招募）
1 期
A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infectionsSymptoms of Covid-19 infectionMedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 100000004862EUCTR2020-001597-30-GB4D pharma plc90
进行中（未招募）
1 期
The CO-ANNEXIN study; assessing the efficacy and safety of ANXV (recombinant Annexin A5) in moderate tosevere COVID-19.moderate to severe COVID-19 pneumoniaEUCTR2021-002200-12-NLMUMC AZm12